Research Article

QiangGuYin Modulates the OPG/RANKL/RANK Pathway by Increasing Secretin Levels during Treatment of Primary Type I Osteoporosis

Figure 2

Effect of QiangGuYin (QGY) treatment on the expression of secretin in mice from different groups. Data are expressed as the mean ± SD (n = 6). vs. the Con group; vs. the Sec-kno group. Groups are as follows: control group (Con), secretin overexpression group (Sec-over), secretin overexpression control group (Sec-over-Con), secretin overexpression + QGY group (Sec-over + Q), secretin knockdown group (Sec-kno), secretin knockdown control group (Sec-kno-Con), and secretin knockdown + QGY group (Sec-kno + Q).